Cybin Announces Closing of Upsized Bought contract providing

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (“Cybin” or the “Company”), a biotechnology business focused on progressing psychedelic therapeutics, is very happy to announce so it has closed its previously announced bought deal […]